Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene Variation
Andrea Gaedigk, Scott T. Casey, Michelle Whirl‐Carrillo, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 3, pp. 542-545
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

PharmVar GeneFocus: CYP2B6
Zeruesenay Desta, Ahmed El‐Boraie, Li Gong, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 1, pp. 82-97
Open Access | Times Cited: 214
Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing
Igor Stevanovski, Sanjog R. Chintalaphani, Hasindu Gamaarachchi, et al.
Science Advances (2022) Vol. 8, Iss. 9
Open Access | Times Cited: 124
Pharmacogenomics in practice: a review and implementation guide
Danya Kabbani, Reem Akika, Ahmed Wahid, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 50
PharmVar GeneFocus: SLCO1B1
Laura B. Ramsey, Li Gong, Seung‐been Lee, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 113, Iss. 4, pp. 782-793
Open Access | Times Cited: 38
CYP3A4 and CYP3A5 Genotyping Recommendations
Victoria M. Pratt, Larisa H. Cavallari, Makenzie L. Fulmer, et al.
Journal of Molecular Diagnostics (2023) Vol. 25, Iss. 9, pp. 619-629
Open Access | Times Cited: 36
Updated DPYDHapB3 haplotype structure and implications for pharmacogenomic testing
Amy Turner, Cyrine E. Haidar, Wenjian Yang, et al.
Clinical and Translational Science (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 23
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy
Julio D. Duarte, Cameron D. Thomas, Craig R. Lee, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 4, pp. 939-947
Open Access | Times Cited: 13
DPYD Genotyping Recommendations
Victoria M. Pratt, Larisa H. Cavallari, Makenzie L. Fulmer, et al.
Journal of Molecular Diagnostics (2024) Vol. 26, Iss. 10, pp. 851-863
Closed Access | Times Cited: 11
CYP2D6 allele frequencies and copy number variants in Chinese Han population: a large retrospective study
Qing‐Yuan Sun, Yue Luan, Bin-Liang Tong, et al.
Research Square (Research Square) (2025)
Closed Access | Times Cited: 1
Identification of Genetic Variants Associated with Pravastatin and Pitavastatin Pharmacokinetics
Anssi J. H. Mykkänen, E. Katriina Tarkiainen, Suvi Taskinen, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 1
PharmVar GeneFocus: CYP2C9
Katrin Sangkuhl, Karla Claudio‐Campos, Larisa H. Cavallari, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 3, pp. 662-676
Open Access | Times Cited: 55
Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG)
Marwan K. Tayeh, Andrea Gaedigk, Matthew P. Goetz, et al.
Genetics in Medicine (2022) Vol. 24, Iss. 4, pp. 759-768
Open Access | Times Cited: 36
Promises and challenges in pharmacoepigenetics
Delaney A. Smith, Marie C. Sadler, Russ B. Altman
Cambridge Prisms Precision Medicine (2023) Vol. 1
Open Access | Times Cited: 20
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy
K.M. Robinson, Seenae Eum, Zeruesenay Desta, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 4, pp. 932-938
Closed Access | Times Cited: 7
Genetic ancestry in Population Pharmacogenomics unravels distinct geographical patterns related to drug toxicity
Kariofyllis Karamperis, Sonja Katz, Federico Melograna, et al.
iScience (2024) Vol. 27, Iss. 10, pp. 110916-110916
Open Access | Times Cited: 6
Characterization of CYP2D6 Pharmacogenetic Variation in Sub‐Saharan African Populations
David Twesigomwe, Britt I. Drögemöller, Galen E.B. Wright, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 113, Iss. 3, pp. 643-659
Open Access | Times Cited: 25
Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank
Binglan Li, Katrin Sangkuhl, Ryan Whaley, et al.
The American Journal of Human Genetics (2023) Vol. 110, Iss. 10, pp. 1628-1647
Open Access | Times Cited: 15
Advancing CYP2D6 Pharmacogenetics through a Pharmacoequity Lens
Oyinlade Kehinde, Laura B. Ramsey, Andrea Gaedigk, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 1, pp. 69-76
Closed Access | Times Cited: 13
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics
X.M. Hart, Gerhard Gründer, Nicolas Ansermot, et al.
The World Journal of Biological Psychiatry (2024) Vol. 25, Iss. 9, pp. 451-536
Closed Access | Times Cited: 5
In-silico screening and analysis of missense SNPs in human CYP3A4/5 affecting drug-enzyme interactions of FDA-approved COVID-19 antiviral drugs
Amro A. Abdelazim, Mohamad Maged, Ahmed I. Abdelmaksoud, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Pharmacogenomic markers associated with drug-induced QT prolongation: a systematic review
Marlene Schouby Bentestuen, Cleo‐Aron Weis, Caroline Bækmann Jeppesen, et al.
Pharmacogenomics (2025), pp. 1-20
Open Access
New Resources to Identify Characterized DNA Reference Materials for PGx and HLA Testing: The Genetic Testing Reference Material (GeT-RM) Program PGx Search Tool and GeT-RM Consolidated PGx and HLA Table
Laura Scheinfeldt, Dara Kusic, Andrea Gaedigk, et al.
Journal of Molecular Diagnostics (2025)
Closed Access
Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysis
Mariamena Arbitrio, Marianna Milano, Maria Lucibello, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Impact of CYP2C:TG Haplotype on CYP2C19 Substrates Clearance In Vivo, Protein Content, and In Vitro Activity
Pablo Zubiaur, Paula Soria‐Chacartegui, Erin C. Boone, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 5, pp. 1033-1042
Open Access | Times Cited: 12
Star allele search: a pharmacogenetic annotation database and user-friendly search tool of publicly available 1000 Genomes Project biospecimens
Neda Gharani, Gennaro Calendo, Dara Kusic, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top